Total IPO volume of Chinese companies 2023, by sector
In 2023, the domestic initial public offering value of Chinese companies from the biotechnology and pharmaceutical industry amounted to over 31 billion yuan. Chinese companies went public despite the outbreak of COVID-19 and the resulting turbulences at various financial markets around the world. The Chinese government tries to develop the domestic financial market to incentivize Chinese companies to list at home.